(Q39653487)

13 September 2017

De novo expression of CD44 variants in sporadic and hereditary gastric cancer (English)

1 reference

13 September 2017

2

1 reference

13 September 2017

10

1 reference

13 September 2017

11

1 reference

13 September 2017

Fátima Carneiro

9

0 references

author name string

Cristiana Branco da Cunha

1

1 reference

13 September 2017

Xiaogang Wen

3

1 reference

13 September 2017

Bárbara Gomes

4

1 reference

13 September 2017

Sónia Sousa

5

1 reference

13 September 2017

Gianpaolo Suriano

6

1 reference

13 September 2017

Maritie Grellier

7

1 reference

13 September 2017

David G Huntsman

8

1 reference

13 September 2017

20 September 2010

1 reference

13 September 2017

Laboratory Investigation

1 reference

13 September 2017

90

1 reference

13 September 2017

11

1 reference

13 September 2017

1604-1614

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.155

13 September 2017

0 references

cites work

CD44 is the principal cell surface receptor for hyaluronate

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

21 January 2018

The CD44 protein family.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

CD44 and the adhesion of neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Expression of CD44 is repressed in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Identification of gastric cancer stem cells using the cell surface marker CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

De-novo expression of CD44 and survival in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

E-cadherin mutations and cell motility: a genotype-phenotype correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Germline CDH1 deletions in hereditary diffuse gastric cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Gastric cancer: new genetic developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

CD44 is required for two consecutive steps in HGF/c-Met signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

HGF-promoted motility in primary human melanocytes depends on CD44v6 regulated via NF-kappa B, Egr-1, and C/EBP-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

CD44v6 promotes proliferation by persisting activation of MAP kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

CD44v6: a potential marker of malignant transformation in intestinal metaplasia of the stomach? An immunohistochemical study using tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Variant expression of CD44 in preneoplastic lesions of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Gastric achlorhydria in H/K-ATPase-deficient (Atp4a(-/-)) mice causes severe hyperplasia, mucocystic metaplasia and upregulation of growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Prevention of tumor metastasis formation by anti-variant CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Cancer nanotechnology: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Expression of CD44 and Its Clinical Implication in Diffuse–Type and Intestinal–Type Gastric Adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

Early Gastric Cancer in Young, Asymptomatic Carriers of Germ-Line E-Cadherin Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

E-cadherin changes in gastric carcimona

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

CD44 isoforms in prognosis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

7 January 2021

CD44 variant exon epitopes in primary breast cancer and length of survival

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

7 January 2021

Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

7 January 2021

Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

7 January 2021

Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

7 January 2021

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

7 January 2021

A novel region of amplification at 11p12-13 in gastric cancer, revealed by representational difference analysis, is associated with overexpression of CD44v6, especially in early-onset gastric carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

7 January 2021

Significance of CD44v6 expression in gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

7 January 2021

Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.155

7 January 2021

10.1038/LABINVEST.2010.155

Identifiers

DOI

1 reference

13 September 2017

1 reference